NADPH oxidase 4 attenuates cerebral artery changes during the progression of marfan syndrome

Yara Onetti, Thayna Meirelles, Ana P. Dantas, Katrin Schröder, Elisabet Vila, Gustavo Egea, Francesc Jiménez-Altayó

Producció científica: Contribució a una revistaArticleRecercaAvaluat per experts

12 Cites (Scopus)

Resum

© 2016 the American Physiological Society. Marfan syndrome (MFS) is a connective tissue disorder that is often associated with the fibrillin-1 (Fbn1) gene mutation and characterized by cardiovascular alterations, predominantly ascending aortic aneurysms. Although neurovascular complications are uncommon in MFS, the improvement in Marfan patients' life expectancy is revealing other secondary alterations, potentially including neurovascular disorders. However, little is known about small-vessel pathophysiology in MFS. MFS is associated with hyperactivated transforming growth factor (TGF)-β signaling, which among numerous other downstream effectors, induces the NADPH oxidase 4 (Nox4) isoform of NADPH oxidase, a strong enzymatic source of H2O2. We hypothesized that MFS induces middle cerebral artery (MCA) alterations and that Nox4 contributes to them. MCA properties from 3-, 6-, or 9-mo-old Marfan (Fbn1C1039G/+) mice were compared with those from age/sex-matched wild-type littermates. At 6 mo, Marfan compared with wild-type mice developed higher MCA wall/lumen (wild-type: 0.081 ± 0.004; Marfan: 0.093 ± 0.002; 60 mmHg; P < 0.05), coupled with increased reactive oxygen species production, TGF-β, and Nox4 expression. However, wall stiffness and myogenic autoregulation did not change. To investigate the influence of Nox4 on cerebrovascular properties, we generated Marfan mice with Nox4 deficiency (Nox4−/−). Strikingly, Nox4 deletion in Marfan mice aggravated MCA wall thickening (cross-sectional area; Marfan: 6,660 ± 363 μm2; Marfan Nox4−/−: 8,795 ± 824 μm2; 60 mmHg; P < 0.05), accompanied by decreased TGF-β expression and increased collagen deposition and Nox1 expression. These findings provide the first evidence that Nox4 mitigates cerebral artery structural changes in a murine model of MFS.
Idioma originalEnglish
Pàgines (de-a)H1081-H1090
RevistaAmerican Journal of Physiology - Heart and Circulatory Physiology
Volum310
Número9
DOIs
Estat de la publicacióPublicada - 1 de maig 2016

Fingerprint

Navegar pels temes de recerca de 'NADPH oxidase 4 attenuates cerebral artery changes during the progression of marfan syndrome'. Junts formen un fingerprint únic.

Com citar-ho